Check out your Company Bowl for anonymous work chats.
Developing treatments for neurodegenerative diseases is one of the toughest challenges in drug discovery. High failure rates, complex mechanisms, and slow progression in clinical trials have long plagued the field. But now, AI is breaking barriers. https://lnkd.in/gztHB2A9 On September 18, our upcoming webinar will dive deep into how AI is accelerating the development of new treatments, speeding up clinical trials, and helping biotechs and specialty pharma alike overcome these challenges. Unlock insights on: ▪ How AI can improve drug discovery success rates ▪ The role AI plays in personalizing treatment and optimizing trials ▪ Ways to shorten timelines and improve outcomes for neurodegenerative disorders Register today and be part of the future of neurodegenerative drug development: https://lnkd.in/gztHB2A9 #Neurodegenerative #DrugDevelopment #AI #ClinicalTrials #Biotech #CNSResearch #AIinHealthcare hashtag#AtTFS hashtag#Webinar
Developing treatments for neurodegenerative diseases is one of the toughest challenges in drug discovery. High failure rates, complex mechanisms, and slow progression in clinical trials have long plagued the field. But now, AI is breaking barriers. https://lnkd.in/gztHB2A9 On September 18, our upcoming webinar will dive deep into how AI is accelerating the development of new treatments, speeding up clinical trials, and helping biotechs and specialty pharma alike overcome these challenges. Unlock insights on: ▪ How AI can improve drug discovery success rates ▪ The role AI plays in personalizing treatment and optimizing trials ▪ Ways to shorten timelines and improve outcomes for neurodegenerative disorders Register today and be part of the future of neurodegenerative drug development: https://lnkd.in/gztHB2A9 #Neurodegenerative #DrugDevelopment #AI #ClinicalTrials #Biotech #CNSResearch #AIinHealthcare #AtTFS #Webinar
As a global, mid-size #OphthalmologyCRO, TFS is proud to partner with MAXO and Retinai to bring innovative AI-driven solutions to clinical trials in dry eye disease. Learn more about this groundbreaking partnership below! By integrating advanced technology into our studies, we’re enhancing both the speed and precision of data collection and analysis, ultimately accelerating impactful drug development. We're excited about the possibilities this collaboration will unlock for patients and the future of ophthalmology clinical research.
We couldn’t let this week pass without spotlighting our incredible Talent Acquisition Team in honor of #GlobalTalentAcquisitionDay! Learn more about our resourcing solutions and dedicated team: https://lnkd.in/e3UnhHq Their relentless pursuit of the perfect match—ensuring the right talent meets the right opportunity—is what sets TFS apart in the industry. With expertise in clinical resourcing and functional service provision, our team is not just filling roles but shaping the future of global clinical research. We celebrate their dedication and the vital role they play in advancing healthcare through talent excellence! #TFSTrailblazers #TogetherWeMakeADifference
Discover the TFS difference in TMF! Led by industry experts, our TMF delivery team is committed to providing unparalleled compliance and efficiency. Read our recent article to learn more about what sets us apart: https://lnkd.in/ewwxFmnX #AtTFS, we collaborate closely with our sponsors, ensuring every document is where it needs to be—safeguarded, accessible, and audit-ready. #ReadNow to see how our services stand out in the crowded CRO landscape. #TMF #ClinicalCRO #ClinicalResearchExcellence
We’re excited to be among leading experts and innovators in ophthalmology at this year’s #EURETINA conference. Join us to learn more about our proven track record of driving groundbreaking ophthalmology studies: https://lnkd.in/erBP3kFE Whether you’re looking to accelerate your clinical trials or need a partner with deep ophthalmology expertise, we’re here to help you every step of the way. Don’t miss this opportunity to connect with our #OphthalmologyCRO team and explore how we can collaborate to advance eye health. hashtag#TogetherWeMakeADifference
#AtTFS, we understand the impact of leveraging AI to transform CNS clinical trials. Join our webinar to discover how #AI can improve success rates in #neurodegenerative drug development: https://lnkd.in/gztHB2A9 Our experts Anne Marie Nagy, PhD and Sara Doan will explore innovative methods to enhance patient recruitment, optimize study protocols, and deepen data analysis. Register today! #ClinicalResearch #CNS #DrugDevelopment
#AtTFS, we believe true progress begins with equality. This Women's Equality Day, we honor the incredible women who paved the way for our female leaders, helping shape the dynamic, inclusive workplace we cherish today. Listen in as Ahuva Koren shares her powerful story of mentorship, inspiration, and the enduring impact of women's equality in the workplace. Join us on our journey toward a more inclusive and equal future. #TogetherWeMakeADifference #WomensEqualityDay #WomenInScience
The #TFSTeam is ready for September, a month packed with exciting industry events! We'll be traveling the globe in attendance at several pivotal conferences, including EURETINA, ECNP, and EADV. Join us: https://tfscro.com/events/ European Society of Retina Specialists (EURETINA) European College of Neuropsychopharmacology (ECNP) European Academy of Dermatology and Venereology
TFS is on the move, participating in the best events the industry has to offer—including #OCTSoCal2024! Exhibiting, speaking, and networking, we’re excited to connect in many ways at the conference: https://lnkd.in/eDSVHyYT Swing by our exhibit to #TalkWithTFS and catch our speaking presentation to tap into the expertise that drives innovation in clinical trials. Don’t miss this chance to meet the bright minds behind our customers' success. See you in San Diego!
